Simplex Trading’s PMV Pharmaceuticals PMVP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1K Sell
8,181
-19,681
-71% -$25K ﹤0.01% 7346
2025
Q4
$34.8K Buy
27,862
+7,121
+34% +$9.54K ﹤0.01% 5981
2025
Q3
$29K Buy
20,741
+20,670
+29,113% +$28.6K ﹤0.01% 7015
2025
Q2
$0 Buy
+71
New +$70 ﹤0.01% 9507
2025
Q1
Sell
-16,935
Closed -$25K 9394
2024
Q4
$25K Buy
16,935
+5,224
+45% +$8.27K ﹤0.01% 6515
2024
Q3
$17K Sell
11,711
-19,005
-62% -$29.4K ﹤0.01% 6811
2024
Q2
$49K Buy
30,716
+20,476
+200% +$36.9K ﹤0.01% 6118
2024
Q1
$17K Buy
10,240
+5,288
+107% +$9.88K ﹤0.01% 7230
2023
Q4
$15K Sell
4,952
-34,407
-87% -$91K ﹤0.01% 7147
2023
Q3
$241K Buy
39,359
+28,667
+268% +$197K ﹤0.01% 4159
2023
Q2
$66K Buy
+10,692
New +$56K ﹤0.01% 5545
2023
Q1
Sell
-982
Closed -$8K 9876
2022
Q4
$8K Buy
+982
New +$10.5K ﹤0.01% 7742
2022
Q3
Sell
-48,757
Closed -$704K 10664
2022
Q2
$694K Buy
+48,757
New +$710K ﹤0.01% 3048
2022
Q1
Sell
-24
Closed -$423 11172
2021
Q4
$0 Buy
+24
New +$580 ﹤0.01% 11217

Other funds holding PMVP

Simplex Trading's PMVP Position: Q1 2026 in Review

Simplex Trading reduced its PMV Pharmaceuticals (PMVP) stake by 71% in Q1 2026, selling an estimated $25K and leaving 8,181 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7346.

Simplex Trading first reported a position in PMVP in Q4 2021 and has held it in 14 quarters since. The position peaked at $694K in Q2 2022. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Simplex Trading held 8,181 shares of PMV Pharmaceuticals worth $10.1K as of Q1 2026.
  • Simplex Trading sold 19,681 PMV Pharmaceuticals shares in Q1 2026, an estimated $25K.
  • PMV Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7346 holding.
  • Simplex Trading first reported a position in PMV Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
  • Simplex Trading's PMV Pharmaceuticals position peaked at $694K in Q2 2022.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.